etoposide has been researched along with hoe 33342 in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cohen, GM; Dinsdale, D; Ormerod, MG; Skilleter, DN; Snowden, RT; Sun, XM | 1 |
| Baguley, BC; Finlay, GJ | 1 |
| Morgan, SA; Smith, PJ; Watson, JV | 1 |
| al-Achi, A; Herman, TS; Holden, SA; Pfeffer, MR; Teicher, BA | 1 |
| Filatov, MV; Varfolomeeva, EY | 1 |
| Ling, V; Shapiro, AB | 1 |
| Bloom, SE; Lee, MY; Muscarella, DE; Rachlinski, M | 1 |
| Smith, PJ; Wiltshire, M | 1 |
| Durand, RE; Olive, PL | 1 |
| Hartley, JA; Hochhauser, D; Tolner, B | 1 |
| Drobchenko, EA; Filatov, MV; Levina, VV; Shabalina, EV; Sukhareva, EB | 1 |
| Dwarakanath, BS; Khaitan, D; Ravindranath, T | 1 |
| Drobchenko, EA; Levina, VV; Shabalina, EV | 1 |
| Mashima, T; Matsuura, M; Miyata, S; Okabe, S; Sato, S; Seimiya, H; Sugimoto, Y; Tsuruo, T | 1 |
| Asanuma, H; Hasegawa, T; Hirata, K; Hirohashi, Y; Inoda, S; Ishitani, K; Kondo, T; Morita, R; Nakatsugawa, M; Nishizawa, S; Sato, N; Takahashi, A; Tamura, Y; Terui, T; Torigoe, T; Tsuruma, T | 1 |
| Evangelatov, A; Skrobanska, R; Yordanov, G | 1 |
| Ahn, JS; Asami, Y; Erikson, RL; Jang, JH; Kim, BY; Kim, SO; Kim, YS; Kwon, YT; Lee, KS; N R, T; Sakchaisri, K; Soung, NK; Thimmegowda, NR | 1 |
21 other study(ies) available for etoposide and hoe 33342
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes.
Topics: Animals; Apoptosis; Benzimidazoles; Cell Separation; Dexamethasone; DNA Damage; Etoposide; Flow Cytometry; Microscopy, Electron; Rats; Thymus Gland | 1992 |
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
Topics: Acridines; Amsacrine; Animals; Antineoplastic Agents; Benzimidazoles; Bisbenzimidazole; Colonic Neoplasms; Doxorubicin; Drug Synergism; Etoposide; Fluorescent Dyes; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
Detection of multidrug resistance and quantification of responses of human tumour cells to cytotoxic agents using flow cytometric spectral shift analysis of Hoechst 33,342-DNA fluorescence.
Topics: Benzimidazoles; Carcinoma, Small Cell; Cell Line, Transformed; Cell Nucleus; Cell Survival; DNA, Neoplasm; Drug Resistance; Etoposide; Flow Cytometry; Fluorescent Dyes; Humans; Lung Neoplasms; Lymphocytes; Tumor Cells, Cultured | 1991 |
The interaction of cisplatin plus etoposide with radiation +/- hyperthermia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Survival; Cisplatin; Combined Modality Therapy; Etoposide; Fibrosarcoma; Flow Cytometry; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiotherapy Dosage | 1990 |
Active dissociation of Hoechst 33342 from DNA in living mammalian cells.
Topics: Benzimidazoles; DNA; Ellipticines; Etoposide; Fluorescence; HeLa Cells; Humans; Novobiocin; Topoisomerase II Inhibitors | 1995 |
Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Binding Sites; Biological Transport; Cell Line; Cell Membrane; Colchicine; Cricetinae; Cricetulus; Dactinomycin; Daunorubicin; Doxorubicin; Etoposide; Fluorescence; Fluorescent Dyes; Kinetics; Liposomes; Protein Binding; Quercetin; Rhodamine 123; Rhodamines; Vinblastine | 1997 |
Cell death in the avian blastoderm: resistance to stress-induced apoptosis and expression of anti-apoptotic genes.
Topics: Animals; Apoptosis; bcl-X Protein; Benzimidazoles; Blastoderm; Chick Embryo; Drug Resistance; Etoposide; Gene Expression Regulation, Developmental; HSP70 Heat-Shock Proteins; Microscopy, Fluorescence; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Stress, Physiological; Temperature; Tumor Cells, Cultured; Vincristine | 1998 |
Cytometry of antitumor drug-intracellular target interactions.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Cycle; DNA; DNA Fragmentation; DNA Topoisomerases, Type I; Drug Delivery Systems; Etoposide; Flow Cytometry; Fluorescent Dyes; Humans; Ligands; Microscopy, Confocal; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2001 |
Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Communication; Cell Separation; Cell Size; Chromatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Neoplasms; Spheroids, Cellular; Tumor Cells, Cultured | 2001 |
Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Benzimidazoles; Bisbenzimidazole; Cell Line; Distamycins; DNA Footprinting; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Gene Expression Regulation; Humans; Isoenzymes; Mice; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic | 2001 |
[A cross drug resistance of mammalian cells with a high efficiency of "DNA clearing"].
Topics: Animals; Benzimidazoles; CHO Cells; Cricetinae; Cross-Linking Reagents; DNA; DNA Damage; Drug Resistance, Multiple; Enzyme Inhibitors; Ethidium; Etoposide; Fluorescent Dyes; Mitomycin; Nucleic Acid Synthesis Inhibitors | 2002 |
2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines.
Topics: Adenosine Triphosphate; Antimetabolites; Antineoplastic Agents, Phytogenic; Benzimidazoles; Brain Neoplasms; Camptothecin; Carcinoma, Squamous Cell; Cell Survival; Deoxyglucose; DNA Damage; Drug Interactions; Enzyme Inhibitors; Etoposide; Glioma; Humans; Radiation-Sensitizing Agents; Topoisomerase Inhibitors; Tumor Cells, Cultured | 2004 |
A new human breast carcinoma cell line resistant to DNA-damaging drugs.
Topics: Benzimidazoles; Breast Neoplasms; DNA; DNA Damage; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Tumor Cells, Cultured | 2004 |
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzimidazoles; Caspases; Catalysis; Cell Line, Tumor; Cell Survival; Coenzyme A Ligases; Cytochrome c Group; Dose-Response Relationship, Drug; Etoposide; Fluorescent Antibody Technique; Fluorescent Dyes; Glioma; Humans; Indoles; Injections, Subcutaneous; Isoenzymes; Mice; Mice, Nude; Neoplasm Transplantation; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Triazenes; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |
Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells.
Topics: Animals; Antigens; Antineoplastic Agents; Benzimidazoles; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Etoposide; Humans; Irinotecan; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; T-Lymphocytes, Cytotoxic | 2011 |
Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzimidazoles; Cell Line, Tumor; Chemistry, Pharmaceutical; Colloids; Coloring Agents; Enbucrilate; Etoposide; Fluorescent Dyes; Humans; Indicators and Reagents; Light; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Scattering, Radiation; Tetrazolium Salts; Thiazoles | 2013 |
STK295900, a dual inhibitor of topoisomerase 1 and 2, induces G(2) arrest in the absence of DNA damage.
Topics: Aniline Compounds; Antineoplastic Agents, Phytogenic; Benzimidazoles; Camptothecin; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Neoplasm; Dose-Response Relationship, Drug; Etoposide; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; HeLa Cells; Hep G2 Cells; HT29 Cells; Humans; Immunoblotting; MCF-7 Cells; Molecular Structure; Neoplasms; Phosphorylation; Topoisomerase Inhibitors | 2013 |